CD4 and tuberculosis: In the SAPiT trial, the mortality rate in 429 patients with CD4 cell counts up to 500 cells/μl who initiated ART during TB treatment was 56% lower (95% confidence interval: 21%–75%, p = 0.003) than in patients who initiated ART after completion of TB treatment [57].